IL13Ra2-CAR T cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for IL13Ra2-CAR T cells, covering 2025-07-10 to 2025-07-10. Get the full timeline:
Most recent: Clinical Trial Update: IL13Ra2-CAR T Cells With or Without Nivolumab and Ipilimumab in Treating Patients With GBM [Phase 1]